Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Entamoeba histolytica | Niemann-Pick C1 protein, putative | 0.0099 | 0.0381 | 0.5 |
Plasmodium vivax | SWIB/MDM2 domain-containing protein, putative | 0.1376 | 1 | 0.5 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.049 | 0.3322 | 0.5 |
Leishmania major | hypothetical protein, conserved | 0.049 | 0.3322 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.1376 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.049 | 0.3322 | 0.3304 |
Trichomonas vaginalis | conserved hypothetical protein | 0.1376 | 1 | 0.5 |
Echinococcus multilocularis | SWI:SNF matrix associated | 0.1376 | 1 | 1 |
Trypanosoma cruzi | Zn-finger in Ran binding protein and others, putative | 0.049 | 0.3322 | 0.5 |
Echinococcus multilocularis | Upstream activation factor subunit UAF30 | 0.1376 | 1 | 1 |
Toxoplasma gondii | SWIB/MDM2 domain-containing protein | 0.1376 | 1 | 1 |
Brugia malayi | Zn-finger in Ran binding protein and others containing protein | 0.049 | 0.3322 | 0.3057 |
Trypanosoma brucei | hypothetical protein, conserved | 0.049 | 0.3322 | 0.5 |
Echinococcus multilocularis | expressed conserved protein | 0.0093 | 0.0336 | 0.0336 |
Schistosoma mansoni | hypothetical protein | 0.049 | 0.3322 | 0.3049 |
Echinococcus multilocularis | SWI:SNF matrix associated | 0.1376 | 1 | 1 |
Trypanosoma cruzi | mitochondrial RNA binding complex 1 subunit, putative | 0.049 | 0.3322 | 0.5 |
Trypanosoma brucei | hypothetical protein, conserved | 0.049 | 0.3322 | 0.5 |
Echinococcus multilocularis | Niemann Pick C1 protein | 0.0142 | 0.0701 | 0.0701 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.049 | 0.3322 | 0.5 |
Trypanosoma cruzi | Zn-finger in Ran binding protein and others/FYVE zinc finger, putative | 0.049 | 0.3322 | 0.5 |
Leishmania major | hypothetical protein, conserved | 0.049 | 0.3322 | 0.5 |
Echinococcus multilocularis | Zinc finger, RanBP2 type | 0.049 | 0.3322 | 0.3322 |
Echinococcus multilocularis | Nuclear pore complex protein Nup153 | 0.049 | 0.3322 | 0.3322 |
Brugia malayi | Zn-finger in Ran binding protein and others containing protein | 0.049 | 0.3322 | 0.3057 |
Trypanosoma brucei | mitochondrial RNA binding complex 1 subunit | 0.049 | 0.3322 | 0.5 |
Trypanosoma cruzi | mitochondrial RNA binding complex 1 subunit, putative | 0.049 | 0.3322 | 0.5 |
Loa Loa (eye worm) | SWIB/MDM2 domain-containing protein | 0.1376 | 1 | 1 |
Echinococcus granulosus | Niemann Pick C1 protein | 0.0099 | 0.0381 | 0.0047 |
Schistosoma mansoni | RNA binding protein | 0.049 | 0.3322 | 0.3049 |
Brugia malayi | Zn-finger in Ran binding protein and others containing protein | 0.049 | 0.3322 | 0.3057 |
Mycobacterium tuberculosis | Possible penicillin-binding protein | 0.0232 | 0.1379 | 0.5 |
Plasmodium vivax | hypothetical protein, conserved | 0.1376 | 1 | 0.5 |
Onchocerca volvulus | 0.1376 | 1 | 1 | |
Echinococcus granulosus | Niemann Pick C1 protein | 0.0142 | 0.0701 | 0.0378 |
Loa Loa (eye worm) | hypothetical protein | 0.049 | 0.3322 | 0.3304 |
Trypanosoma brucei | Zn-finger in Ran binding protein and others/FYVE zinc finger, putative | 0.049 | 0.3322 | 0.5 |
Leishmania major | hypothetical protein, conserved | 0.049 | 0.3322 | 0.5 |
Echinococcus multilocularis | ring and YY1 binding protein | 0.049 | 0.3322 | 0.3322 |
Trypanosoma cruzi | WLM domain containing protein, putative | 0.049 | 0.3322 | 0.5 |
Trypanosoma cruzi | WLM domain containing protein, putative | 0.049 | 0.3322 | 0.5 |
Echinococcus multilocularis | SWI:SNF matrix associated | 0.1376 | 1 | 1 |
Brugia malayi | SWIB/MDM2 domain containing protein | 0.1376 | 1 | 1 |
Echinococcus granulosus | Zinc finger RanBP2 type | 0.049 | 0.3322 | 0.309 |
Leishmania major | hypothetical protein, conserved | 0.049 | 0.3322 | 0.5 |
Echinococcus granulosus | SWI:SNF matrix associated | 0.1376 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.049 | 0.3322 | 0.3304 |
Brugia malayi | Zn-finger in Ran binding protein and others containing protein | 0.049 | 0.3322 | 0.3057 |
Echinococcus granulosus | Nuclear pore complex protein Nup153 | 0.049 | 0.3322 | 0.309 |
Echinococcus granulosus | zinc finger protein Ran binding | 0.049 | 0.3322 | 0.309 |
Schistosoma mansoni | hypothetical protein | 0.1376 | 1 | 1 |
Leishmania major | hypothetical protein, conserved | 0.049 | 0.3322 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.049 | 0.3322 | 0.3304 |
Echinococcus granulosus | Upstream activation factor subunit UAF30 | 0.1376 | 1 | 1 |
Plasmodium falciparum | SWIB/MDM2 domain-containing protein | 0.1376 | 1 | 1 |
Toxoplasma gondii | DNA topoisomerase domain-containing protein | 0.1376 | 1 | 1 |
Trypanosoma cruzi | Zn-finger in Ran binding protein and others, putative | 0.049 | 0.3322 | 0.5 |
Brugia malayi | YY1-associated factor 2 | 0.049 | 0.3322 | 0.3057 |
Echinococcus granulosus | ring and YY1 binding protein | 0.049 | 0.3322 | 0.309 |
Loa Loa (eye worm) | hypothetical protein | 0.0099 | 0.0381 | 0.0355 |
Schistosoma mansoni | TRABID protein (C64 family) | 0.049 | 0.3322 | 0.3049 |
Schistosoma mansoni | zinc finger protein | 0.049 | 0.3322 | 0.3049 |
Chlamydia trachomatis | SWIB complex protein | 0.1376 | 1 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.049 | 0.3322 | 0.3304 |
Loa Loa (eye worm) | brahma associated protein | 0.1376 | 1 | 1 |
Plasmodium falciparum | SWIB/MDM2 domain-containing protein | 0.1376 | 1 | 1 |
Echinococcus multilocularis | zinc finger protein Ran binding | 0.049 | 0.3322 | 0.3322 |
Schistosoma mansoni | fusion | 0.049 | 0.3322 | 0.3049 |
Schistosoma mansoni | hypothetical protein | 0.1376 | 1 | 1 |
Chlamydia trachomatis | DNA topoisomerase I | 0.1376 | 1 | 0.5 |
Brugia malayi | brahma associated protein 60 kDa | 0.1376 | 1 | 1 |
Echinococcus multilocularis | Niemann Pick C1 protein | 0.0099 | 0.0381 | 0.0381 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.049 | 0.3322 | 0.5 |
Schistosoma mansoni | brg-1 associated factor | 0.1376 | 1 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
GI50 (functional) | -4.05 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the HL-60(TB) Leukemia cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -4 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the SN12C Renal cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -4 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the NCI-H23 Non-Small Cell Lung cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -4 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the UO-31 Renal cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -4 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the ACHN Renal cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -4 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the HOP-92 Non-Small Cell Lung cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -4 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the SF-539 Central Nervous System cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -4 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the SK-MEL-5 Melanoma cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -4 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the MALME-3M Melanoma cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.